Adam Spence, of Wall, N.J., entered a partnership with Microspec Corp., of Peterborough, N.H., a manufacturer of tight-tolerance medical tubing, that will allow the former to offer reinforced catheter shafts with Microspec's proprietary multidurometer extrusions.
Dedham, Mass.-based Alimed Inc. has won a group purchasing agreement for mobile medical carts with Premier Inc., of Charlotte, N.C. Effective July 1, the agreement allows Premier members, at their discretion, to take advantage of special pricing and terms prenegotiated by Premier for Alimed mobile medical carts.
Arrayit Corp., of Sunnyvale, Calif., signed allergy testing contracts with a consortium of medical clinics nationwide. The network comprises 178 medical clinics in 29 states. The clinics are using the testing services to assist physicians in diagnosing and treating allergy and asthma across a range of medical specialties.
Avadim Technologies Inc., of Asheville, N.C., reported that the U.S. Department of Veterans Affairs (VA) has added Avadim's clinical brands for hospitals and the military to a medical device, supplies and services contract held by ADS Inc. Theraworx Protect is now a contracted product and available for use throughout the Veterans Health Administration.
St. Paul, Minn.-based Cardiovascular Systems Inc. (CSI) signed an agreement with Aerolase Corp., of Tarrytown, N.Y., to codevelop a laser atherectomy device for physicians to use in treating multiple forms of arterial disease. As part of the agreement, CSI made an undisclosed equity investment in Aerolase and will make additional equity investments as development milestones are met.
Convey Health Solutions Inc., of Fort Lauderdale, Fla., reported the opening of a 38,000 sq. ft. distribution facility and the creation of more than 40 jobs in Lenexa, Kan. The new facility will inventory, track and ship over-the-counter (OTC) products and supplies nationwide to Medicare and Medicaid members. The company said it expects to triple its OTC shipping capacity with this expansion.
Cytosorbents Corp., of Monmouth Junction, N.J., said it has expanded the distribution of its Cytosorb blood purification technology to a total of 53 countries worldwide. Recently added countries (and distributors), accounting for an additional 31 million people, include: Lebanon (Pharma World LB); Bosnia, Herzegovina and Croatia (Medis); Estonia, Latvia and Lithuania (Sia Scanmed); Moldova (Smart Medical Solutions); and Montenegro and Serbia (Mar Medica). Cytosorbents also announced the change of the company's distributor in the U.K. to Chalice Medical Ltd.
Hebron Technology Co. Ltd., of Wenzhou City, China, signed nonbinding memoranda of understanding (MoUs) with two U.S.-based companies. The company signed an MoU with Silicon Valley-based Bionic Sound for a collaboration on projects related to hearing aid devices. The MoU with Vor Sense relates to diagnostic medical equipment.
Interpace Diagnostics Group Inc., of Parsippany, N.J., received a letter dated July 30 notifying the company that it has regained compliance with the requirement of the Nasdaq Stock Market to maintain a minimum closing bid price of $1.00 per share.
Pure Capital completed its acquisition of 217,696 American depositary receipts of Medigus Ltd., of Omer, Israel, and now holds more than 5 percent of the company. Pure Capital sent a letter to the CEO, chairman of the board and directors, calling for an immediate general assembly meeting of the shareholders of Medigus and the dismissal of the internal members of the board. In the letter, Pure Capital detailed previous actions that it believes have been harmful to shareholders, including continual capital consolidations and capital raises under unfavorable terms.
Salt Lake City-based Nu-Med Plus Inc. launched a program to attain ISO 13485 certification. The news comes in anticipation of FDA 510(k) fillings for Nu-Med Plus nitric oxide delivery devices.
The Philadelphia Pediatric Medical Device Consortium (PPDC) unveiled its latest round of seed grants to companies developing medical devices for children. The consortium chose six companies in a competition to receive seed grants of up to $50,000. The devices are an airway clearance system, a urological biofeedback monitor, a vesicoureteral reflux diagnostic tool, an eye-tracking test for traumatic brain injury patients, a cranio-maxillofacial distractor and a vision acuity test for preverbal children.
Secant Group, of Telford, Pa., will collaborate with Orgenesis Inc., of Germantown, Md., and Atvio Biotech Ltd., of Nesher, Israel, to develop and commercialize biodegradable and injectable scaffold technologies for use in advanced cell therapies. Under the agreement, Secant will engineer and prototype 3D scaffolds, while Atvio will provide expertise in cell coatings, cell production, process development and support services. The collaboration will be financed in part through a $1.8 million grant from the Israel-U.S. Binational Industrial R&D Foundation, as well as additional funding provided by Orgenesis and Secant Group.
Santa Barbara, Calif.-based Sientra Inc. reported its investment in opening a new state-of-the-art Sientra Lab and Innovation Center of Excellence (SLICE) near its corporate headquarters. SLICE is expected to open this month, with a focus on driving development, research and innovation of surgical products, services and solutions within its breast products business segment.